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Carotid body tumors are the most common head and neck region paragangliomas and are located on carotid bifurcation. They are rare tumors of neuroendocrine origin. [1] These benign tumors are considered malignant due to the surrounding tissues and intracranial spread. The first-line treatment of carotid body tumors which occur as slowly-growing masses in the neck is surgical resection. [2] The definitive diagnosis is based on computed tomography (CT) and magnetic resonance imaging (MRI). Due to its intense vascular structure, there may be serious bleeding during the removal of the tumor. Vascular and cranial nerve damage due to dissection and retraction can be also seen. [3] Preoperative embolization is an effective method to reduce tumor vascularity and size. Herein, we report two adult cases who were treated surgically following selective embolization with the diagnosis of a unilateral carotid body tumor and discuss the effects of tumor embolization on surgery.
CASE REPORT
Case 1-A 57-year-old male patient was admitted due to swelling on the right side of the neck. On physical examination, a still painless mass was detected in a diameter of 4¥4 cm in the mid lower third of the right sternocleidomastoid muscle. Carotid CT angiography revealed a vascularized mass in the right carotid bifurcation 6¥5 cm in size surrounding the right common, internal and external carotid arteries ( Figure 1a ). A written informed consent was obtained from the patient. Selective tumor embolization was performed before resection (Figure 1b Physical examination revealed a painless, horizontally moving mass with dimensions of 4¥4 cm in the lower third of the left sternocleidomastoid muscle. Ear, nose, and throat examination was performed and a 4¥4 cm mass in the left carotid bifurcation surrounding the vascular structures was detected on cervical MRI. The patient was, then, referred to the cardiovascular surgery department. Carotid CT angiography revealed a mass with vascularization surrounding the common, internal, and external carotid arteries (Figure 2a ). A written informed consent was obtained from the patient. Preoperative selective tumor embolization was performed before resection (Figure 2b, c) . Under general anesthesia, the mass was removed surgically in the subadventitial plane (Figure 2d -f). The patient was discharged on the postoperative Day 3 without any complication.
DISCUSSION
The most recommended surgical method in the treatment of carotid body tumors is subadventitial resection and is affected mainly by the tumor's relation with the carotid arteries. Shamblin classification frequently used to define the pathology is based on its relation with the carotid arteries. [3] In Type 1, the tumor is in close proximity to the vessels. In Type 2, the carotid arteries are partially wrapped. In Type 3, the vessels are totally wrapped by the tumor. The first two are easier to remove from the vascular and neural structures, while the other may require vascular reconstruction. [3] In all, however, surgical intervention should be performed by an experienced surgeon who is familiar with all surgical procedures. In both cases presented herein, the internal and external carotid arteries were almost completely wrapped with the tumor, although there was no invasion to the arterial wall. Therefore, they were accepted to be Shamblin Class 2, and there was no need for graft interposition or arterial reconstruction. In such cases, subadventitial dissection can be carefully made without harming carotid arteries.
Embolization of carotid body tumors has become an important aid in the treatment of these tumors. The main indications of tumor embolization are to control the nourishing arteries which cannot be reached surgically, to decrease surgical morbidity by reducing blood loss, to shorten the operation time, to prepare the ground for complete surgical resection, to reduce the risk of damage to the adjacent tissues, and to provide a better vision in the surgical field. [1] Although a clear guide is not defined, it is usually applied in large diameter (>3 cm) or Shamblin Type 2 and Type 3 tumors. [1, 4] In a systematic review of 465 patients, it was reported that embolization facilitated excision and shortened duration of surgery with reduced blood loss. The low amount of hemorrhage facilitates excision and allows complete resection, reducing the risk of recurrences. The time from preoperative embolization to surgery should be a maximum of 48 hours. Similarly, in our cases, we performed surgery within 48 hours following embolization. Both of our cases were accepted as Shamblin Class 2; therefore, we performed selective tumor embolization prior to surgical resection to reduce intraoperative bleeding and to make the excision comfortable without leaving a residual tumor.
In addition to studies reporting reduction in intraoperative bleeding, easy excision, and improvement in surgical outcomes, there are also studies showing no statistically significantly different results. A comprehensive study by Cobb et al. [5] found no improvement in perioperative morbidity and mortality in carotid body tumors with preoperative embolization. An increase was observed in the embolization group in terms of bleeding and neurological complications. [5] In a series of 96 patients, it was documented that embolization performed approximately in half of the patients, did not cause a statistically significant difference in terms of operative time, blood loss, vascular reconstruction requirement, and postoperative nerve deficits. [6] Despite these studies opposing embolization, the necessity of questioning the use of embolization in terms of cost and benefit in the treatment of carotid body tumors arises.
In conclusion, although it is evident that more comprehensive, prospective studies on the use of selective tumor embolization in carotid body tumors are needed, a thorough assessment of the vascular structure of the tumor and its Shamblin classification play a key role in the selection of patients undergoing embolization.
